| | | | | | | | | Sponsored | | Most of what determines how an assay performs is decided before you run your first qPCR reaction, sequence a sample, or build an immunoassay or flow cytometry panel. The Assay Development Handbook covers the pre-analytical decisions that get locked in early and how to make them before they're permanent. |
|
|
| | |
| |
| | |
|
|
| | | | | | Where should molecular infectious disease testing be performed? Join Dr. Kenneth Gavina TOMORROW for a free CE webinar exploring centralized versus decentralized testing and its impact on workflow, turnaround time, diagnostic performance, and patient care. |
|
|
|
| |
| | |
|
|
| | | | | | New sequencing technologies aim to address challenges with turnaround times, complex genomic regions, and workflow flexibility. Explore how advances in sequencing chemistry could support drug discovery, oncology research, and personalized medicine. |
|
|
|
| |
| | |
|
|
| | | | | | Juneau, AK is the safest city to reside in America, while New Orleans, LA is the least safe, according to a new analysis from WalletHub. |
|
|
|
| |
| | |
|
|
| | | | | | QIAGEN (“Company”) and the EQT XI fund (“EQT Private Equity”) announced an agreement under which Crown NL Bidco B.V. (the “Bidder”) announced its decision to make an all-cash voluntary public takeover offer for the acquisition of all outstanding QIAGEN shares at €46.50 per share. |
|
|
|
| |
| | |
|
|
| | | | | | Medical Laboratory Observer (MLO) is conducting a series of polls on point-of-care testing (POCT) in clinical laboratories. Tell us: What is the biggest POCT challenge your lab faces? |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
